02.08.2025 aktualisiert
100 % verfügbar
Pharmaceutical HEOR, Market Access and Pricing Strategy Consultant
Walchwil, Schweiz MBA
Skills
Klinische ArbeitenCustomer Value PropositionWirtschaftliche TheorienGesundheitsökonomieInternationaler HandelPharma-MarketingNeurowissenschaftenPreisstrategienStakeholder ManagementSeltene Krankheiten (Fachkompetenz)GesundheitssystemProjektlieferung
Market Access Strategy
Development and execution of market access strategies to accelerate and influence pricing and reimbursement decisions for pharmaceutical products across global markets.
Pricing Strategy
Development of sophisticated pricing strategies for pharmaceutical products, including price defense strategies to maintain pricing against competition.
Health Economics
Strong technical expertise in health economics, creating health economic models and generating evidence to demonstrate clinical and cost effectiveness.
Rare Disease Expertise
Significant experience in rare diseases and neuroscience, with specialized knowledge of treatment pathways and market dynamics.
Value Proposition Development
Creation of compelling value propositions and messaging for pharmaceutical products to demonstrate value to payers and stakeholders.
Global Healthcare Systems Knowledge
Thorough knowledge of integrated healthcare systems in Europe, US and LATAM regions.
Early Access Programs
Design and implementation of early access programs to facilitate patient access to treatments prior to full market authorization.
Development and execution of market access strategies to accelerate and influence pricing and reimbursement decisions for pharmaceutical products across global markets.
Pricing Strategy
Development of sophisticated pricing strategies for pharmaceutical products, including price defense strategies to maintain pricing against competition.
Health Economics
Strong technical expertise in health economics, creating health economic models and generating evidence to demonstrate clinical and cost effectiveness.
Rare Disease Expertise
Significant experience in rare diseases and neuroscience, with specialized knowledge of treatment pathways and market dynamics.
Value Proposition Development
Creation of compelling value propositions and messaging for pharmaceutical products to demonstrate value to payers and stakeholders.
Global Healthcare Systems Knowledge
Thorough knowledge of integrated healthcare systems in Europe, US and LATAM regions.
Early Access Programs
Design and implementation of early access programs to facilitate patient access to treatments prior to full market authorization.
Sprachen
EnglischMutterspracheFranzösischgut
Projekthistorie
Providing small to medium sized pharma companies with pricing, reimbursement and market access expertise in Europe and the US, specializing in rare diseases, respiratory diseases, internal medicine and neuroscience.
Developed pricing and market access strategy, value story, health economic model and executed launch plans for Arimoclomol (treatment of Newman Pick Disease) in EU and US.
Developed pricing and value strategy and led launch preparations for Melflufen (treatment of Multiple Myeloma).